Treatment
Medication clinical trials
We’re tracking 7,435 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07193849RecruitingPhase 4
Zinc oxide vs MEBO for stage 2 pressure ulcers
This trial compares two topical treatments—zinc oxide and MEBO—for stage 2 pressure ulcers (bedsores that are open but not too deep). It aims to see which works better to help these sores heal in patients at King Abdullah Medical City.
Mecca, Western ReaganAges 18 years+ - NCT07193888Recruiting
Navitor valve study for aortic stenosis
This study is testing the Navitor valve, a device to replace a narrowed aortic heart valve without open-heart surgery. It will track how well the valve works in people who are already good candidates for this procedure.
FukuokaAges 18–100 - NCT07195123Recruiting
Testing the SMART IBD app for kids with IBD
This study tests whether a smartphone app called SMART IBD can help children with IBD take their medications more consistently. It is for children who are currently missing more than 1 in 7 doses of their daily or weekly IBD medication.
Cincinnati, OhioAges 13–17 - NCT07195162Recruiting
Testing a digital tool for pain management
This trial is testing a digital workflow system to help doctors manage pain. It may be a good fit if you've had pain lasting at least a month.
HaifaAges 18–80 - NCT07195513Recruiting
Helping advanced cancer patients connect to palliative care via electronic reporting
This trial uses electronic surveys to identify symptoms and unmet needs in people with advanced cancer, then connects them to palliative care services. It aims to improve quality of life by making sure patients get the extra support they need.
Lebanon, New HampshireAges 18 years+ - NCT07195500Recruiting
Imaging scans for neuroblastoma and related tumors
This trial uses special PET/CT or SPECT/CT scans that light up certain types of tumor cells (neuroblastoma and pheochromocytoma/paraganglioma). The scans help doctors see where the cancer is, how far it has spread, and whether treatment is working.
Nanjing, JiangsuAges 6 months+ - NCT07195656Recruiting
Electrical stimulation device for overactive bladder
This trial tests a non-surgical device that uses mild electrical stimulation to treat overactive bladder. It may help if you have a sudden, strong need to pee often or wake up at night to pee.
Beverly Hills, CaliforniaAges 21 years+ - NCT07195799RecruitingPhase 2
Linperlisib with CPT for relapsed or refractory non-Hodgkin lymphoma
This trial tests a combination of drugs (linperlisib, cyclophosphamide, prednisone, and thalidomide) for people with certain types of non-Hodgkin lymphoma that have come back or not responded to previous treatments. It aims to see if this combination can help control the disease.
Nanjing, JiangsuAges 18 years+ - NCT07196397Recruiting
Polish Registry of Heart Nerve Procedures
This registry tracks people who have had or plan to have a procedure that changes the nerves controlling heart rate, such as cardioneuroablation. It aims to better understand and treat conditions like inappropriate tachycardia, POTS, and fainting spells.
RzeszówAges 18 years+ - NCT07196462Recruiting
Brain stimulation to reduce cannabis craving in schizophrenia
This study tests if a non-invasive brain stimulation technique can help reduce cravings for cannabis in people with schizophrenia. It aims to see if this approach can improve outcomes for those who use cannabis and have a psychotic disorder.
Nashville, TennesseeAges 18–65 - NCT07196839Recruiting
Study of heart medication and amyloid levels over time
This study looks at how a heart medication (tafamidis) affects amyloid protein levels in the blood over time. It may help doctors understand how well the treatment works for people with a specific type of heart disease caused by amyloid buildup (ATTR-CM).
Dallas, TexasAges 30–80 - NCT07197450RecruitingEarly Phase 1
Study of XH02 for hypoparathyroidism
This trial tests an investigational drug called XH02 for people with hypoparathyroidism (low parathyroid hormone) that is not well controlled with standard calcium and vitamin D treatments. The goal is to see if XH02 is safe and effective at managing symptoms.
BeijingAges 18–65 - NCT07197905RecruitingPhase 2
Iron for POTS: A study on iron deficiency and heart rate
This trial tests if giving iron to people with POTS who have low iron stores can improve symptoms. It's for those with POTS and a ferritin level below 50.
Nashville, TennesseeAges 18–45 - NCT07198061Recruiting
Cold Plasma for Diabetic Foot Ulcers After Leg Artery Treatment
This study tests whether adding cold atmospheric plasma treatment to standard care helps heal foot ulcers in people with diabetes who have recently had a procedure to open blocked leg arteries. The goal is to see if this approach is safe and more effective than current care alone.
Anshan, LiaoningAges 18–80 - NCT07199829Recruiting
Vitamin D and K for military healthcare workers
This study tests whether taking vitamin D3 and K2 supplements can improve health in military healthcare workers who have low vitamin D levels. If you qualify, you will stop any current vitamin D or K supplements and take the study supplement for 4.5 months.
Tacoma, WashingtonAges 18–69 - NCT07200466Recruiting
Personalized risk assessment for endometrial cancer
This trial uses a prediction model to better estimate the risk of endometrial cancer coming back. It aims to help doctors and patients make more personalized treatment decisions after surgery.
Arnhem, GelderlandAges 45 years+ - NCT07201194Recruiting
Acupuncture for chemotherapy nausea
This trial tests if acupuncture can help reduce nausea in people who still feel sick despite taking their regular anti-nausea medication during chemotherapy.
VejleAges 18 years+ - NCT07201948Recruiting
Lifestyle program to control high blood pressure
This study tests a team-based lifestyle program to help control or prevent high blood pressure. It focuses on people in Tennessee who are at higher risk and want to make lasting health changes.
Nashville, TennesseeAges 30–80 - NCT07202156Recruiting
Ultrasound helps deliver melasma treatment
This trial tests a new way to deliver a medicine (tranexamic acid) into melasma patches using ultrasound waves. It aims to see if the ultrasound helps the medicine work better to lighten the dark spots.
Nanjing, JiangsuAges 20–55 - NCT07202897RecruitingPhase 3
Preventing blood clots in hypertrophic cardiomyopathy with rivaroxaban
This trial tests if the blood thinner rivaroxaban can prevent strokes in people with hypertrophic cardiomyopathy who have early signs of damage in their left atrium (the heart's upper chamber). You may qualify if you have this condition, are in a normal heart rhythm, and are between 40 and 80 years old.
AngersAges 40–80 - NCT07203352RecruitingPhase 3
Targeted drugs plus chemo for T-cell acute lymphoblastic leukemia
This trial tests whether adding targeted drugs to standard chemotherapy works better for adults newly diagnosed with T-ALL. If you have not had any prior treatment for leukemia, this study might be an option.
Guangzhou, GuangdongAges 18–70 - NCT07203729RecruitingPhase 2
Trastuzumab rezetecan for her2-low breast cancer with visceral crisis
This trial tests a new antibody-drug combination called trastuzumab rezetecan (SHR-A1811) in people with a specific type of breast cancer (HER2-low) that has spread and is causing serious organ problems (visceral crisis). The goal is to see if this treatment can help when organs like the liver or lungs are rapidly failing due to the cancer.
Beijing, Beijing MunicipalityAges 18–75 - NCT07203781Recruiting
Breathing machine settings and their effect on breathing effort
This study is testing how different settings on a breathing machine affect your breathing effort and drive. It may help doctors find the best ventilator settings for patients with severe low oxygen levels.
Nijmegen, GelderlandAges 18 years+ - NCT07205263Recruiting
AI-guided minimally invasive surgery for brain bleeding
This trial tests a minimally invasive surgery guided by artificial intelligence to treat spontaneous brain bleeding. It aims to improve recovery by precisely removing the clot with less damage to healthy brain tissue.
Hangzhou, ZhejiangAges 18 years+
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,435 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.